Commercial
Advanced Search

Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies
07.03.09v

Policy

MEDICALLY NECESSARY 

INDEX OF MEDICALLY NECESSARY INDICATIONS
 
This policy addresses numerous medically necessary indications for electrodiagnostic studies. Please see below for the specific medical neces​sity criteria. (NOTE: Not Medically Necessary and Experimental/Investigational sections below must also be reviewed).

Electrodiagnostic (EDX) Studies​​​​
​Needle Electromyography (NEMG) and Nerve Conduction Studies (NCS)
​NEMG Performed Without NCS
  • N​EMG of anal and urethral sphincter
  • NEMG for precise muscle location for intramuscular agents
  • NEMG of the larynx
​​NCS Performed Without NEMG
Other Electrodiagnostic Studies 
  • Single Fiber EMG (SFEMG)
  • ​Neuromuscular junction testing
  • ​Somatosensory evoked potentials (SEPs)

NEEDLE ELECTROMYOGRAPHY (NEMG) AND NERVE CONDUCTION STUDIES (NCS)
​
  • Needle electromyography (NEMG) and nerve conduction studies (NCS), which provides amplitude, latency, configuration, and conduction velocity data, are considered medically necessary ​when they are performed and interpreted at the same time, on site, and in real time for any of the following circumstances:​
    • ​Plexopathy (including idiopathic, traumatic, inflammatory, or infiltrative, radiation-induced, brachial plexopathies (e.g. neuralgic amyotrophy, thoracic outlet syndrome), and lumbosacral plexopathies (e.g. diabetic, non-diabetic lumbosacral radiculoplexus neuropathy
    • Focal neuropathies (e.g., entrapment neuropathies or compressive lesions/syndromes such as carpal tunnel syndrome, ulnar neuropathy, tarsal tunnel syndrome, femoral neuropathy, saphenous neuropathy, lateral femoral cutaneous neuropathy, peroneal (fibular) neuropathy, tibial neuropathies, sciatic neuropathy)
    • Generalized neuropathies such as metabolic (e.g., diabetic, uremic), toxic, hereditary or immune-mediated
    • Motor neuron disease (e.g., amyotrophic lateral sclerosis [ALS] or Lou Gehrig's disease)
    • Myopathy - including inflammatory myopathies such as polymyositis and dermatomyositis, congenital myopathies, congenital and hereditary dystrophic and nondystrophic myopathies, including myotonic muscular dystrophy, acquired myopathies (drug induced myopathy associated with statins, thyroid related), metabolic myopathies (e.g., McArdle disease) (including polymyositis and dermatomyositis; myotonic and congenital myopathies)
    • Myotonic disorders (e.g., drug induced myotonia)
    • Neuromuscular junction disorders (e.g., myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism)
    • Polyneuropathies
    • Radiculopathy – cervical, thoracic, or lumbosacral
    • Spinal cord disorders (i.e., myelopathy)
    • Symptom-based presentations such as “pain in limb", weakness, cramping/twitching, disturbance of skin sensation or “paresthesia" when appropriate pre-test evaluations are inconclusive, and the clinical assessment unequivocally supports the need for the study
    • Traumatic nerve lesions, for diagnosis and prognosis
    • Mononeuropathy and polyneuropathy (metabolic, degenerative, hereditary)
​​​​NEMG PERFORMED WITHOUT NCS
​
NEMG when performed without NCS is considered medically necessary for the following situations, including but not limited to:
  • Conditions that affect the urethral or anal sphincter
    • Constipation
    • Diabetic autonomic (poly) neuropathy ​
    • Neurogenic conditions (e.g., multiple sclerosis, spinal cord injury, paralysis, or motor neuron disease)
    • Bladder outlet obstruction (a blockage at the base of the bladder that reduces or prevents the flow of urine into the urethra)
    • Urinary incontinence 
    • Fecal incontinence
  • Precise muscle location with NEMG for injection of intramuscular agents (e.g., botulinum toxin, phenol or other substances for nerve blocking or chemodenervation) for the following conditions:
    • Paralysis (e.g., monoplegia, hemiplegia, diplegia, quadriplegia, and paraplegia)
    • Hyperhydrosis
    • Bladder and anal disorders or incontinence​
    • Facial spasm
    • Chronic migraine
    • Nerve palsy: oculomotor, trochlear, abducent
    • Strabismus (e.g., esotropia, extropia, and cyclotropia)

  •  Conditions that affect the larynx

    • Paralysis of vocal cords and larynx
    • Dysphagia
    • Dysphonia
​​​​​NCS PERFORMED WITHOUT NEMG

NCS when performed without NEMG are considered medically necessary for the following situations:
  • ​​​Individuals treated with anticoagulants such as warfarin (Coumadin), rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban (Eliquis), edoxaban (Lixiana), clopidogrel (Plavix), ticagrelor (Brilinta), ticlopidine (Ticlid), prasugrel (Effient), varapaxar (Zontivity), dipyridamole, cilostazol (Pletal)
  • Individuals with significant lymphedema in the affected extremity
  • Individuals being evaluated for carpal tunnel syndrome or tarsal tunnel syndrome​
​RELATED ELECTRODIAGNOSTIC STUDIES

Single-fiber electromyography (SFEMG) is considered medically necessary for the following conditions:

  • Ocular myasthenia
  • Myasthenia gravis
  • Myasthenic syndrome (e.g., Lambert-Eaton myasthenic syndrome)

Neuromuscular junction testing (NJT) is considered medically necessary for the following conditions:

  • Neuromuscular junction disorders (e.g., myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism)
  • Carnitine deficiency
  • Glycogen storage diseases (e.g., Pompe disease, Forbes-Cori disease, McArdle disease)
  • Myopathy (including myotosis)
  • Myalgia
  • Muscle weakness and atrophy
  • Dysphagia

Somatosensory evoked potentials (SEPs) and central motor evoked potentials (CMEPs) are considered medically necessary for the following conditions:​

  • Spinal cord trauma
  • Degenerative, non-traumatic spinal cord lesions (e.g., cervical spondylosis with myelopathy)
  • Multiple sclerosis
  • Spinocerebellar degeneration
  • Myoclonus
  • Coma
  • Intraoperative monitoring
  • Subacute combined degeneration
  • Other diseases of myelin (e.g., adrenoleukodystrophy, adrenomyeloneuropathy, metachromatic leukodystrophy, and Pelizaeus-Merzbacher disease)
  • Syringomyelia
  • Hereditary spastic paraplegia​​
Please refer to Attachment A of this policy for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) guidelines for recommended maximum number of EMG.

NOT MEDICALLY NECESSARY

Needle EMG and/or NCS for any other indication is considered not medically necessary and, therefore, not covered because the available published peer-reviewed literature does not support its use in the diagnosis illness or injury. 
Examples of indications include but are not limited to:
  • ​Delayed and incomplete interpretation of the NEMG study; NEMG study must be performed and interpreted with the NCS on site and in real time (excluding conditions listed above)
  • Non-invasive EDX studies using portable hand-held devices or automated point of care nerve conduction monitoring systems, which are incapable of real-time waveform display and analysis
  • Testing for polyneuropathy of diabetes in individuals without clinical deficits or for the sole purpose of monitoring disease intensity or treatment efficacy
  • NCSs accomplished with discriminatory devices that use fixed anatomic templates and computer-generated reports used as an adjunct to physical examination routinely on all individuals
  • Physiologic recording of movement disorder symptoms, including bradykinesia, dyskinesia, and tremor using wearable devices with accelerometers or gyroscopes
  • NCS or EMG for muscle pain without the presence of other abnormalities on examination or in laboratory testing
  • Surface electromyography (SEMG)
  • Macroelectromyography (macro-EMG)​
  • Needle electrooculomyography
  • NEMG of the hemidiaphragm
  • Blink reflex test​
  • NEMG for the following situations:
    • ​Definitive diagnosis based on paraspinal NEMG in areas with scar from past surgeries (e.g., previous laminectomies)​
    • Isolated neck or back pain after a motor vehicle accident
    • Exclusive testing of intrinsic foot muscles in the diagnosis of proximal lesions
    • Pattern-setting limited limb muscle examinations, without paraspinal muscle testing for the diagnosis of radiculopathies
    • Premature needle EMG testing after trauma when EMG changes have not taken place
    • Multiple uses of needle EMG in the same individual at the same location of the same limb for the purpose of optimizing botulinum toxin injections have not been supported
​EXPERIMENTAL/INVESTIGATIONAL

The following services are considered experimental/investigational and, therefore, not covered because the safety and/or effectiveness of this service cannot be established by review of the available published peer-reviewed literature:​ ​

  • Motor and/or sensory nerve conduction using preconfigured electrode arrays, with or without F-wave study
  • Quantitative Sensory Testing (QST) (e.g., hot-cold, touch, vibration) 
  • Sensory Nerve Conduction Threshold (sNCT) Testing including Pain Perception Threshold (PPT), Pain Tolerance Threshold (PTT), and Voltage-Actuated Sensory Nerve Conduction Threshold (VsNCT)
PROFESSIONAL AND TECHNICAL COMPONENT REIMBURSEMENT
  • Only physicians (MD/DO) are eligible to receive reimbursement for the professional component of EMG. Physicians may also receive reimbursement for the technical component if they performed that service.
  • Nonphysician professional providers (e.g., physical therapists) are only eligible to receive reimbursement for the technical component of EMG.
STATE OF NEW JERSEY

 In the state of New Jersey, as defined by the scope of practice regulations, only a physician may perform needle EMG studies.

REQUIRED DOCUMENTATION

Documentation of the performing professional provider's qualifications must be made available to the Company upon request.

The individual's medical record must reflect the medical necessity for the care provided. These medical records may include, but are not limited to: records from the health care professional's office, hospital, nursing home, home health agencies, therapies, and test reports.

The Company may conduct reviews and audits of services to our members, regardless of the participation status of the provider. All documentation is to be available to the Company upon request. Failure to produce the requested information may result in a denial for the service.

Guidelines

MINIMUM STANDARDS FOR NEEDLE ELECTROMYOGRAPHY (EMG)

The Company has adopted the minimum standards for needle EMG as defined by the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Minimum standards include the following:
  • Testing should be performed using equipment that assesses all parameters of the recorded signals.
    • Studies that are performed with devices designed only for screening, rather than diagnosing, are not eligible under this policy.
  • The number of tests performed should be the minimum that are necessary to establish an accurate diagnosis, which may include evaluation of one or more nerves that have normal test results for comparative purposes.
Please refer to Attachment A of this policy for the AANEM recommendations regarding the maximum number of studies that should be performed for each condition, as well as examples of clinical situations when additional testing may be appropriate. These recommendations should not apply if the individual requires evaluation by more than one consultant (i.e., a second opinion or an expert opinion at a tertiary care center) in a given year or if the individual requires evaluation for a second diagnosis in a given year.

CLINICAL SPECIALIZATION PROGRAMS

Eligible professional providers performing a needle EMG should have sufficient knowledge and experience in needle EMG. Competency to perform needle EMG can be demonstrated through training from a clinical specialization program. Candidates are able to demonstrate their level of competence from a certification organization such as, but not limited to, the following:
  • American Board of Electrodiagnostic Medicine (ABEM)
  • American Board of Psychiatry and Neurology Added Qualifications in Clinical Neurophysiology (ABPN-CN)
  • American Board of Clinical Neurophysiology, Inc. (ABCN)
  • American Board of Neurophysiological Monitoring (ABNM)
  • American Board of Registration of Electrodiagnostic Technologists (ABRET)
  • American Society of Electroneurodiagnostic Technologists, Inc. (ASET)
SURFACE ELECTROMYELOGRAM

Electromyographic studies performed with surface electrodes (i.e., SEMG) instead of needle technology (i.e., needle EMG) are not to be billed with the standard electrodiagnostic code (i.e., 95860).

In addition, SEMG studies described in this policy are reported using Healthcare Common Procedure Coding System (HCPCS) code S3900. It should not be confused with the type of EMG described in Current Procedural Terminology (CPT) code 51784, in which the physician places a pad in the anal or urethral sphincter and measures the electrical activity when the bladder is filled and during emptying.

BENEFIT APPLICATION

Subject to the terms and conditions of the applicable benefit contract, needle EMG is covered under the medical benefits of the Company’s products when the medical necessity criteria listed in the medical policy are met. However, services that are identified in this policy as not medically necessary are not eligible for coverage or reimbursement by the Company.

US FOOD AND DRUG ADMINISTRATION (FDA) STATUS

The FDA has approved several devices that are used to perform needle EMG.

Description

NEEDLE ELECTROMYOGRAPHY (EMG)


 EMG is the study and recording of the intrinsic electrical properties of skeletal muscles. EMG is performed to diagnose, define, and follow diseases of the peripheral nervous system and muscle. Needle EMG is performed by inserting an electrode through the skin into appropriate muscles, one at a time. The needle translates the amount and intensity of the electrical activity into waveforms that are displayed on a computer screen. Generally, the electrodes are of two types: monopolar or concentric. In addition, needle EMG can be performed as a part of intraoperative neurophysiological monitoring (INM), which monitors the integrity of neural pathways during surgeries where there is a potential for damage to neural integrity.

After the needle EMG is performed on the muscle, the data (the waveforms, sounds, and feel of the muscle) are analyzed to determine if additional muscles need to be studied. The muscles studied will vary depending on the differential diagnosis and the ongoing synthesis of new information that is obtained while the test is being performed. The electromyographer relies on ongoing real-time clinical diagnostic evaluation when deciding whether to continue, modify, or conclude a needle EMG. This requires a comprehensive knowledge base of anatomy, physiology, and neuromuscular diseases, as well as an awareness of the influence of age, temperature, and body height on the results.

Needle EMG results reflect the integrity of the functioning connection between a nerve and its innervated muscle, as well as the integrity of the muscle itself. The axon innervating a muscle is primarily responsible for the muscle's volitional contraction, survival, and trophic functions. Thus, interruption of the axon will alter the EMG.

Neurogenic disorders can be distinguished from myopathic disorders by a carefully performed needle EMG. For example, both polymyositis and amyotrophic lateral sclerosis (ALS) produce manifest weakness; however, polymyositis carries a very different prognosis and treatment than ALS. A needle EMG is essential in making a distinction between the two disorders because the needle electrode allows the muscle's electrical characteristics at rest and during activity to be interpreted by the electromyographer. This interpretation includes an analysis of oscilloscope tracings and the characteristic sounds that are produced by electrical potentials. The final interpretation of the study is a combination of the individual's history, a physical examination, and the muscles tested. Similarly, classification of nerve trauma into axonal versus demyelinating categories, with corresponding differences in prognoses, is possible with a needle EMG.

NERVE CONDUCTION STUDIES (NCS) CONDUCTED WITH NEEDLE EMG


NCS is performed together with a needle EMG. NCS measures the electrical activity of muscles or the integrity of the functioning connection between a nerve and its innervated muscle, as well as the integrity of the muscle itself. The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) recommends that except under unique situations (e.g., presence of lymphedema, current use of anticoagulants), NCS and needle EMG should be performed together in a study for an accurate clinical diagnosis of peripheral nervous system disorders. The reporting of NCS and needle EMG study results should be integrated into a unifying diagnostic impression.​


NCSs may be conducted without NEMG in some situations (e.g., individuals with significant lymphedema, with entrapment neuropathies, or on anticoagulants), but this should be the exception rather than the normal practice pattern.


SINGLE-FIBER EMG


In single-fiber needle EMG, a specially designed needle electrode is used to record and identify action potentials (APs) from individual muscle fibers. These recordings are used to calculate the neuromuscular jitter and the muscle fiber density (FD). Jitter is defined as the variability in time between activation of the motor nerve and generation of the muscle fiber AP; it reflects the normality of nerve-to-muscle transmission. Normal jitter varies among muscles and muscle fibers within individual muscles. To determine if jitter is abnormally increased, statistical analysis is performed from the recordings of a population of muscle fibers within each treated muscle. When neuromuscular transmission is sufficiently abnormal and nerve activation produces no muscle AP, blocking is seen. Increased jitter, blocking, or both may occur in a variety of primary disorders of neuromuscular transmission (e.g., myasthenia gravis). Jitter and FD may be measured in one or more muscles depending on the condition being evaluated and the results of the testing.


NEUROMUSCULAR JUNCTION TESTING


Neuromuscular junction testing, also known as repetitive nerve stimulation, is an electrodiagnostic test that is used to diagnose NMJ disorders such as myasthenia gravis, Lambert-Eaton myasthenic syndrome, and botulism. The test involves recording muscle responses to a series of nerve stimuli and may be used in association with NCSs of the same nerves.


SOMATOSENSORY-EVOKED POTENTIAL (SEP)


While motor and sensory NCS generally detect function in large-caliber peripheral nerve fibers, SEP tests conduction in central sensory pathways. SEP is an extension of the electrodiagnostic evaluation. SEP is a noninvasive study performed by repetitive submaximal stimulation of a sensory or mixed sensorimotor peripheral nerve. Amplitude, peak, and interpeak latency measurements with side-to-side comparisons are used to assess conduction abnormalities. SEP has proven useful in evaluating various conditions including, but not limited to: spinal cord trauma, subacute combined degeneration, nontraumatic spinal cord lesions, and multiple sclerosis.​​


H-REFLEX AND F-WAVE STUDY


Late response (H-reflex and F-wave study) testing is a type of NCS usually performed on nerves more proximal to the spine. The H-reflex involves conduction from the periphery to and from the spinal cord. The H-reflex study involves the assessment of the ​gastrocnemius/soleus muscle complex in the calf and is usually performed bilaterally due to the need to assess symmetrical results in determining abnormalities. The F-wave study is a late response similar to the H-reflex. F-wave studies are used to assess the proximal segments of the motor nerve function and are performed in combination with the examination of motor nerves. Both studies are helpful in diagnosing conditions of radiculopathies, plexopathies, polyneuropathies (particularly with multifocal conduction block, Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy), and proximal mononeuropathies. Late response studies are complementary to NCS and are performed during the same evaluation.


SURFACE EMG (SEMG)


A surface EMG (SEMG) is not the same as a conventional EMG. SEMG involves a noninvasive, computer-based technique that records the electrical impulses of the nerves and muscles through electrodes that are placed on or passed over the surface of the skin. SEMG differs from needle EMG with respect to technical requirements and electrical properties. SEMG electrodes measure from a wide area of muscle, have a relatively narrow frequency band, have low signal resolution, and are highly susceptible to movement artifact. According to the AANEM, there are no clinical indications for the use of SEMG in the diagnosis and treatment of disorders of the nerves or muscles.​


QUANTITATIVE SENSORY TESTING (QST)


QST is the noninvasive assessment and quantification of sensory nerve function, for which there are US Food and Drug Administration (FDA)-approved devices. QST involves psychophysical tests that are performed to provide a quantitative value to the subjective feeling of sensation. A transcutaneous electrical stimulus is used to determine the minimum stimulus that evokes sensation in the individual. Individuals are asked to identify the absence or presence of stimulus by undergoing a forced-choice protocol, with the threshold of perception as the measured response. Proponents of this test claim that neuropathies can be diagnosed by using transcutaneous electrical stimulus. Stimuli used in QST include touch, pressure, pain, temperature, and vibration.


SENSORY NERVE CONDUCTION THRESHOLD (sNCT)​ TESTING


The sNCT is a psychophysical assessment of both central and peripheral nerve functions. It measures the detection threshold of accurately calibrated sensory stimuli. This procedure is intended to evaluate and quantify function in both large and small caliber fibers for the purpose of detecting neurologic disease. Sensory perception and threshold detection are dependent on the integrity of both the peripheral sensory apparatus and peripheral-central sensory pathways. In theory, an abnormality detected by this procedure may signal dysfunction anywhere in the sensory pathway from the receptors, the sensory tracts, the primary sensory cortex, to the association cortex.


This procedure is different and distinct from assessment of nerve conduction velocity, amplitude and latency. It is also different from short-latency somatosensory evoked potentials.​

References

American Academy of Orthopaedic Surgeons. Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline. February 29, 2016. Available at: https://www.aaos.org/globalassets/quality-and-practice-resources/carpal-tunnel/cts_cpg_4-25-19.pdf. Accessed March 20, 2024.

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Model Policy for Nerve Conduction Studies and Needle Electromyography. [AANEM Web site]. December 2022. Available at: https://www.aanem.org/clinical-practice-resources/position-statements/position-statement/model-policy-for-nerve-conduction-studies-and-needle-electromyography. Accessed March 20, 2024.

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Proper performance and interpretation of electrodiagnostic studies. [AANEM Web site]. January 2020. Available at: https://www.aanem.org/docs/default-source/documents/aanem/advocacy/position-statement-proper-performance-of-edx-2014. Accessed March 20, 2024.

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Recommended policy for electrodiagnostic medicine. [AANEM Web site]. January 2023. Available at: https://www.aanem.org/clinical-practice-resources/position-statements/position-statement/recommended-policy-for-electrodiagnostic-medicine. Accessed March 20, 2024.

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Evidenced-Based Review: Use of Surface Electromyography in the Diagnosis and Study of Neuromuscular Disorders. [AANEM Web site]. October 2008. Available at: https://www.aanem.org/clinical-practice-resources/position-statements/position-statement/use-of-surface-electromyography-in-the-diagnosis-and-study-of-neuromuscular-disorders. Accessed March 20, 2024.

Bittman B, Cram JR. Surface electromyography: an electrophysiologic alternative in pain management. Presented at the American Pain Society; 1992; Illinois.


Centers for Medicare & Medicaid Services (CMS). National Coverage Determination (NCD) for 

160.23 Sensory Nerve Conduction Threshold Tests (sNCTs) [CMS website]. Available at: https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=270&NCDver=2. Accessed March 20, 2024.


Chang MH, Liu LH, Lee YC, et al. Comparison of sensitivity of transcarpal median motor conduction velocity and conventional conduction techniques in electrodiagnosis of carpal tunnel syndrome. Clin Neurophysiol. 2006;117(5):984-991.

Cram JR, Lloyd J, Cahn TS. The reliability of EMG muscle scanning. Int J Psychosom. 1994;41(4-Jan):41-45.


De Luca CJ. Use of the surface EMG signal for performance evaluation of back muscles. Muscle Nerve. 1993;16(2):210-216.


du Rose A, Breen A. Relationships between paraspinal muscle activity and lInter-vertebral range of motion. Healthcare (Basel). 2016;4(1). 

Ellestad SM, Nagle RV, Boesler DR, et al. Electromyographic and skin resistance responses to osteopathic manipulative treatment for low-back pain. J Am Osteopath Assoc. 1988;88(8):991-997.

Fowler JR, Munsch M, Tosti R, et al. Comparison of ultrasound and electrodiagnostic testing for diagnosis of carpal tunnel syndrome: study using a validated clinical tool as the reference standard. J Bone Joint Surg Am. 2014;96(17):e148.

Ghosh PS, Sorenson EJ. Diagnostic yield of electromyography in children with myopathic disorders. Pediatr Neurol. 2014;51(2):215-219.


Gooch CL, Weimer LH. The electrodiagnosis of neuropathy: basic principles and common pitfalls. Neurol Clin. 2007;25(1):1-28.

Hanada EY, Johnson M, Hubley-Kozey C. A comparison of trunk muscle activation amplitudes during gait in older adults with and without chronic low back pain. PM R. 2011;3(10):920-928.


Hegmann KT, Travis R, Belcourt RM, et al. Diagnostic tests for low back disorders. J Occup Environ Med. 2019;61(4):e155-e168.


Homan MM, Franzblau A, Werner RA, et al. Agreement between symptom surveys, physical examination procedures and electrodiagnostic findings for the carpal tunnel syndrome. Scand J Work Environ Health. 1999;25(2):115-124.

Humphrey AR, Nargol AV, Jones AP, et al. The value of electromyography of the lumbar paraspinal muscles in discriminating between chronic-low-back-pain sufferers and normal subjects. Eur Spine J. 2005;14(2):175-184.

Hung CC, Shen TW, Liang CC, et al. Using surface electromyography (SEMG) to classify low back pain based on lifting capacity evaluation with principal component analysis neural network method. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:18-21.

Hu Y, Kwok JW, Tse JY, et al. Time-varying surface electromyography topography as a prognostic tool for chronic low back pain rehabilitation. Spine J. 2014;14(6):1049-1056.

Hu Y, Siu SH, Mak JN, et al. Lumbar muscle electromyographic dynamic topography during flexion-extension. J Electromyogr Kinesiol. 2010;20(2):246-255.

Hu Y, Kwok JW, Tse JY, et al. Time-varying surface electromyography topography as a prognostic tool for chronic low back pain rehabilitation. Spine J. 2014;14(6):1049-1056.

Jones SL, Hitt JR, Desarno MJ, et al. Individuals with non-specific low back pain in an active episode demonstrate temporally altered torque responses and direction-specific enhanced muscle activity following unexpected balance perturbations. Exp Brain Res. 2012;221(4):413-426.


Kang PB, McMillan HJ, Kuntz NL, et al. Utility and practice of electrodiagnostic testing in the pediatric population: An AANEM consensus statement. Muscle Nerve. 2020;61(2):143-155.


Kienbacher T, Fehrmann E, Habenicht R, et al. Age and gender related neuromuscular pattern during trunk flexion-extension in chronic low back pain patients. J Neuroeng Rehabil. 2016;13:16.


Kreiner DS, Matz P, Bono CM, et al. Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain. Spine J. 2020;20(7):998-1024.


Lee DH, Claussen GC, Oh S. Clinical nerve conduction and needle electromyography studies. J Am Acad Orthop Surg. 2004;12(4):276-287.

Marciniak C, Armon C, Wilson J, et al. Practice parameter: utility of electrodiagnostic techniques in evaluating patients with suspected peroneal neuropathy: an evidence-based review. Muscle Nerve. 2005;31(4):520-527.

Mohseni Bandpei MA, Rahmani N, Majdoleslam B, et al. Reliability of surface electromyography in the assessment of paraspinal muscle fatigue: an updated systematic review. J Manipulative Physiol Ther. 2014;37(7):510-521.


Mondelli M, Aretini A, Arrigucci U, et al. Clinical findings and electrodiagnostic testing in 108 consecutive cases of lumbosacral radiculopathy due to herniated disc. Neurophysiol Clin. 2013;43(4):205-215.

Neblett R, Brede E, Mayer TG, et al. What is the best surface EMG measure of lumbar flexion-relaxation for distinguishing chronic low back pain patients from pain-free controls? Clin J Pain. 2013;29(4):334-340.


Novitas Solutions, Inc. Local Coverage Article (LCA). A54095: Billing and Coding: Nerve Conduction Studies and Electromyography. (Original: 10/01/2015). Revised: 01/01/2024. Available at: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54095&ver=53&=. Accessed March 20, 2024.


Novitas Solutions, Inc. Local Coverage Article (LCA). A56773: Billing and Coding: Neurophysiology Evoked Potentials (NEPs). (Original: 08/08/2019). Revised: 10/01/2023. Available at: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56773. Accessed March 20, 2024.

Novitas Solutions, Inc. Local Coverage Determination (LCD). L34975:Neurophysiology Evoked Potentials (NEPs). (Original: 10/01/2015). Revised: 12/17/2019. Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=34975&ver=67. Accessed March 20, 2024.

Novitas Solutions, Inc. Local Coverage Determination (LCD). L35081: Nerve Conduction Studies and Electromyography. (Original: 10/01/2015). Revised: 12/10/2013. Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=35081​. Accessed March 20, 2024.


Olney RK, Lewis RA, Putnam TD, et al. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve. 2003;27(1):117-121.

Peach JP, McGill SM. Classification of low back pain with the use of spectral electromyogram parameters. Spine.1998;23(10):1117-1123.

Pullman SL, Goodin DS, Marquinez AI, et al. Clinical utility of surface EMG: report of the therapeutics and technology assessment subcomittee of the American Academy of Neurology. Neurology. 2000;55(2):171-177.


Rabie M, Jossiphov J, Nevo Y. Electromyography (EMG) accuracy compared to muscle biopsy in childhood. J Child Neurol. 2007;22(7):803-808.

Roy SH, Oddsson LI. Classification of paraspinal muscle impairments by surface electromyography. Phys Ther. 1998;78(8):838-851.


Schabrun SM, Elgueta-Cancino EL, Hodges PW. Smudging of the Motor Cortex Is Related to the Severity of Low Back Pain. Spine (Phila Pa 1976). 2017;42(15):1172-1178. 

Sheeran L, Sparkes V, Caterson B, et al. Spinal position sense and trunk muscle activity during sitting and standing in nonspecific chronic low back pain: classification analysis. Spine (Phila Pa 1976). 2012;37(8):E486-495.


Tulipan JE, Lutsky KF, Maltenfort MG, et al. Patient-Reported Disability Measures Do Not Correlate with Electrodiagnostic Severity in Carpal Tunnel Syndrome. Plast Reconstr Surg Glob Open. 2017;5(8): e1440.

U.S. Food and Drug Administration (FDA). Needle Electrodes. 510(k) summary. [FDA Web site]. 10/07/10. Available at: Center for Devices and Radiological Health. Available at: http://www.fda.gov. Accessed March 20, 2024.

Van Damme B, Stevens V, Perneel C, et al. A surface electromyography based objective method to identify patients with nonspecific chronic low back pain, presenting a flexion related movement control impairment. J Electromyogr Kinesiol. 2014;24(6):954-964.​

Coding

CPT Procedure Code Number(s)
MEDICALLY NECESSARY

THE FOLLOWING CODES ARE USED TO REPRESENT Needle Electromyography and Nerve Conduction Studies

95860, 95861, 95863, 95864, 95867, 95868, 95869, 95870, 95885, 95886, 95887, 95907, 95908, 95909, 95910, 95911, 95912, 95913

THE FOLLOWING CODES ARE USED TO REPRESENT Electromyography of Anal or Urethral Sphincter​

51784, 51785

THE FOLLOWING CODE IS USED TO REPRESENT Needle Electromyography for Guidance in Conjunction with Chemodenervation​

​95874
​
THE FOLLOWING CODE IS USED TO REPRESENT NEMG OF THE LARYNX
​
95865

THE FOLLOWING CODE IS USED TO REPRESENT Single Fiber Electromyography (SFEMG)
​
95872
​
THE FOLLOWING CODE IS USED TO REPRESENT Neuromuscular junction testing (NJT)
​​
95937 

​THE FOLLOWING CODES ARE USED TO REPRESENT Somatosensory evoked potentials (SEPs) AND Central Motor Evoked Potentials (CMEPs)
​
95925, 95926, 95927, 95928, 95929, 95938, 95939

NOT MEDICALLY NECESSARY

92265, 95866, 95933  

THE FOLLOWING CODE IS USED TO REPRESENT Macroelectromyography (macro-EMG):

95999 
​
EXPERIMENTAL/INVESTIGATIONAL
​
0106T, 0107T, 0108T, 0109T, 0110T, 95905​
ICD - 10 Procedure Code Number(s)
N/A
ICD - 10 Diagnosis Code Number(s)
MEDICALLY NECESSARY  

See the Following Attachments for the Medically Necessary Indications:

​Attachment​​
​Procedures 
​B
​Needle Electromyography and Nerve Conduction Studies 
​C
​Electromyography of Anal or Urethral Sphincter 
​D
​Needle Electromyography for Guidance in Conjunction with Chemodenervation
​E
​Neuromuscular Junction Testing
​F
​Somatosensory Evoked Potentials ​

Needle Electromyography of the Larynx (CPT 95865 ) IS CONSIDERED MEDICALLY NECESSARY FOR THE FOLLOWING INDICATIONS:
J38.01  Paralysis of vocal cords and larynx, unilateral                                  
J38.02  Paralysis of vocal cords and larynx, bilateral                        
R06.02 Shortness of breath                           
R13.12 Dysphagia, oropharyngeal phase                               
R13.13 Dysphagia, pharyngeal phase                        
R13.14 Dysphagia, pharyngoesophageal phase                                
R13.19 Other dysphagia                                 
R49.0   Dysphonia                              
R49.8   Other voice and resonance disorders

Single Fiber Electromyography (CPT 95872 ) IS CONSIDERED MEDICALLY NECESSARY FOR THE FOLLOWING INDICATIONS:
G70.00 Myasthenia gravis without (acute) exacerbation                                                        
G70.01 Myasthenia gravis with (acute) exacerbation                                                 
G70.1   Toxic myoneural disorders                                                    
G70.2   Congenital and developmental myasthenia                                                    
G70.80 Lambert-Eaton syndrome, unspecified                                                          
G70.81 Lambert-Eaton syndrome in disease classified elsewhere                                                    
G70.89 Other specified myoneural disorders                                                 
G70.9   Myoneural disorder, unspecified                                                        
G73.1   Lambert-Eaton syndrome in neoplastic disease                                                        
G73.3   Myasthenic syndromes in other diseases classified elsewhere                                                         
H02.421 Myogenic ptosis of right eyelid                                                          
H02.422 Myogenic ptosis of left eyelid                                                 
H02.423 Myogenic ptosis of bilateral eyelids                                                   
H05.821 Myopathy of extraocular muscles, right orbit                                                
H05.822 Myopathy of extraocular muscles, left orbit                                                   
H05.823 Myopathy of extraocular muscles, bilateral                                                   
H53.2 Diplopia                                                          
H53.8 Other visual disturbances
HCPCS Level II Code Number(s)
NOT MEDICALLY NECESSARY

S3900 Surface electromyography (EMG)​

EXPERIMENTAL/INVESTIGATIONAL

​G0255 Current perception threshold/sensory nerve conduction threshold (sNCT) test, per limb, any nerve
Revenue Code Number(s)
N/A


Coding and Billing Requirements

Policy History

9/30/2024
9/30/2024
07.03.09
Medical Policy Bulletin
Commercial
{"6593": {"Id":6593,"MPAttachmentLetter":"A","Title":"Recommended Guidelines for Electrodiagnostic Studies","MPPolicyAttachmentInternalSourceId":8125,"PolicyAttachmentPageName":"bd5d0dd0-7aef-454e-8dc4-b2f2d3076a57"},"6594": {"Id":6594,"MPAttachmentLetter":"C","Title":"ICD10 Codes - Electromyography of Anal or Urethral Sphincter","MPPolicyAttachmentInternalSourceId":8688,"PolicyAttachmentPageName":"df932614-9151-41e1-ae2f-25e84bbb540c"},"6595": {"Id":6595,"MPAttachmentLetter":"D","Title":"ICD-10 Codes - Needle Electromyography for Guidance in Conjunction with Chemodenervation","MPPolicyAttachmentInternalSourceId":8689,"PolicyAttachmentPageName":"99da9368-e112-42cb-8f8f-fafd06f3675b"},"6596": {"Id":6596,"MPAttachmentLetter":"E","Title":"ICD10 Codes - Neuromuscular Junction Testing","MPPolicyAttachmentInternalSourceId":8690,"PolicyAttachmentPageName":"04f7f55d-145f-4191-9ff3-a8208f555043"},"6597": {"Id":6597,"MPAttachmentLetter":"F","Title":"ICD10 Codes - Somatosensory Evoked Potentials","MPPolicyAttachmentInternalSourceId":8691,"PolicyAttachmentPageName":"42c2b433-cbd4-4f21-8e16-a2dd5589282b"},"6598": {"Id":6598,"MPAttachmentLetter":"B","Title":"ICD10 Codes - Needle Electromyography and Nerve Conduction Studies","MPPolicyAttachmentInternalSourceId":8820,"PolicyAttachmentPageName":"8b0e85fe-ef7b-4ce4-9a08-298ac2a348fa"},}
No